Alana M Connell
Overview
Explore the profile of Alana M Connell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferng A, Connell A, Marsh K, Qu N, Medina A, Bajaj N, et al.
J Clin Transl Res
. 2019 Mar;
3(2):260-270.
PMID: 30873477
Regenerative medicine, particularly decellularization-recellularization methods via whole-organ tissue engineering, has been increasingly studied due to the growing donor organ shortage. Though numerous decellularization protocols exist, the ideal decellularization protocol for...
2.
Ferng A, Schipper D, Connell A, Marsh K, Knapp S, Khalpey Z
J Cardiothorac Surg
. 2017 Jan;
12(1):7.
PMID: 28126002
Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many...
3.
Ferng A, Marsh K, Fleming J, Conway R, Schipper D, Bajaj N, et al.
Springerplus
. 2016 Dec;
5(1):2057.
PMID: 27995034
Background: Adipose-derived stem/stromal cells (ASCs) isolated from the stromal vascular fraction are a source of mesenchymal stem cells that have been shown to be beneficial in many regenerative medicine applications....
4.
Ferng A, Oliva I, Jokerst C, Avery R, Connell A, Tran P, et al.
Artif Organs
. 2016 Nov;
41(8):727-734.
PMID: 27862058
Since the creation of SynCardia's 50 cc Total Artificial Hearts (TAHs), patients with irreversible biventricular failure now have two sizing options. Herein, a case series of three patients who have...